Objectives The aim of this study is to assess the Generic Price Linkage system and the system that includes Generic Substitution and Reference Pricing by comparing prices of generics and originators and the number of generics entering the market in Austria and in Finland. Policies targeted: Generic Price Linkage, Generic Substitution, Reference Pricing. Stakeholders: Austria: Main Association o...

The use of generic medicines is widely advocated as a means of reducing healthcare costs. Generic drugs need to meet bioequivalence specifications but, with epilepsy, there is concern that permitted differences in bioavailability may be sufficient to allow loss of seizure control or toxicity in susceptible patients. Where generics are dispensed, whether in response to a generic prescription or ...

BACKGROUND In 2011, Manitoba implemented a province-wide program of physician detailing and free sampling for generic atorvastatin to increase use of this generic statin. We examined the impact of this unique combined program of detailing and sampling for generic atorvastatin on the use and cost of statin medicines, market share of generic atorvastatin, the choice of starting statin for new use...

BACKGROUND Internationally, generic medicines are increasingly seen as a key strategy to reduce healthcare expenditure, therefore awareness and knowledge transfer regarding generic medicines are valid areas of research. Although the Internet is a frequently used source of medical information, the accuracy of material found online is variable. The aim of this study was to evaluate information pr...

The objective of this study was to learn more about consumers’ and physicians’ knowledge, attitudes, beliefs generic medicines, as well the problems in guaranteeing medicine acceptance utilization. aim our figure out what would improve physician customer acceptance. included qualitative research with focus group conversations physicians from various fields medicine, a cross-sectional survey 102...

Biological therapies are being used in many chronic conditions. Development of biosimilar medicines gives chances for wider access to biological treatment. The aim the review was present legal regulations marketing authorisation context biosimilars medicines. article focuses on legislation European Union, which established beginning XXI century and is very complex strict. In first part were des...

OBJECTIVE To report the attitudes of community pharmacists in Kabul, Afghanistan, concerning the quality and price of locally manufactured medicines. METHODS A cross-sectional descriptive study, involving a sample of 198 community pharmacists was conducted in Kabul city. RESULTS With a response rate of 100%, most of the respondents 70.7% had 11-20 years experience working as a pharmacist. A...

BACKGROUND Many patients even those with health insurance pay out-of-pocket for medicines. We investigated the availability and prices of essential medicines in the Boston area. METHODS Using the WHO/HAI methodology, availability and undiscounted price data for both originator brand (OB) and lowest price generic (LPG) equivalent versions of 25 essential medicines (14 prescription; 11 over-the...

This paper investigates the determinants of the prices of branded prescription medicines across different regulatory settings and health care systems, taking into account their launch date, patent status, market dynamics and the regulatory context in which they diffuse. By using volume-weighted price indices, this paper analyzes price levels for a basket of prescription medicines and their diff...

BACKGROUND Malaysia's stable health care system is facing challenges with increasing medicine costs. To investigate these issues a survey was carried out to evaluate medicine prices, availability, affordability, and the structure of price components. METHODS AND FINDINGS The methodology developed by the World Health Organization (WHO) and Health Action International (HAI) was used. Price and ...